News

Becton, Dickinson and Company has struggled over the past decade, with a 10-year CAGR of only 5.1%. Read what keeps me on the ...
Becton, Dickinson and Company (BD) has received the US Food and Drug Administration’s (FDA) 510(k) clearance for the Phasix ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance ...
BD has introduced the HemoSphere Alta platform, incorporating predictive algorithms based on AI to manage instability in ...
The Franklin Lakes, New Jersey-based company operates through BD Medical, BD Life Sciences ... For fiscal 2025, analysts expect Becton, Dickinson and Company to report an adjusted EPS of ...
Becton, Dickinson is the world's largest manufacturer ... as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of ...
Valued at a market cap of $57.1 billion, Becton, Dickinson and Company (BDX) is a global medical technology company that ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has launched a new advanced ...
Former Edwards Lifesciences Critical Care Unit, renamed BD Advanced Patient Monitoring, yesterday launched the HemoSphere ...
BD introduces next generation hemodynamic monitoring solution providing clinicians with AI-driven clinical decision support: ...